These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8061853

  • 1. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, Mellein B, Waite R.
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K, Schardt F, Sierakowski B, Weidinger G, Welzel D.
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.
    Guitard C, Lohmann FW, Alfiero R, Ruina M, Alvisi V.
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273
    [Abstract] [Full Text] [Related]

  • 10. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J, Lánská V, Hulínský V.
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [Abstract] [Full Text] [Related]

  • 11. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 12. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
    Bavanandan S, Morad Z, Ismail O, Chandran A, Thayaparan T, Singaraveloo M.
    Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA, Martsevich SIu, Deev AD, Kutishenko NP, Kukushkin SK, Manoshkina EM, Alimova EV, Semenova IuE, Lebedev AV, Koniakhina IP, Zagrebel'nyĭ AV.
    Ter Arkh; 2000 Jun; 72(10):86-9. PubMed ID: 11220888
    [Abstract] [Full Text] [Related]

  • 20. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.